• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

提高严重免疫相关不良事件检测的精准度:大型语言模型与患者记录中疾病国际分类代码的比较分析

Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes in Patient Records.

作者信息

Sun Virginia H, Heemelaar Julius C, Hadzic Ibrahim, Raghu Vineet K, Wu Chia-Yun, Zubiri Leyre, Ghamari Azin, LeBoeuf Nicole R, Abu-Shawer Osama, Kehl Kenneth L, Grover Shilpa, Singh Prabhsimranjot, Suero-Abreu Giselle A, Wu Jessica, Falade Ayo S, Grealish Kelley, Thomas Molly F, Hathaway Nora, Medoff Benjamin D, Gilman Hannah K, Villani Alexandra-Chloe, Ho Jor Sam, Mooradian Meghan J, Sise Meghan E, Zlotoff Daniel A, Blum Steven M, Dougan Michael, Sullivan Ryan J, Neilan Tomas G, Reynolds Kerry L

机构信息

Harvard Medical School, Boston, MA.

Cardiovascular Imaging Research Center, Massachusetts General Hospital, Boston, MA.

出版信息

J Clin Oncol. 2024 Dec 10;42(35):4134-4144. doi: 10.1200/JCO.24.00326. Epub 2024 Sep 3.

DOI:10.1200/JCO.24.00326
PMID:39226489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11692905/
Abstract

PURPOSE

Current approaches to accurately identify immune-related adverse events (irAEs) in large retrospective studies are limited. Large language models (LLMs) offer a potential solution to this challenge, given their high performance in natural language comprehension tasks. Therefore, we investigated the use of an LLM to identify irAEs among hospitalized patients, comparing its performance with manual adjudication and International Classification of Disease (ICD) codes.

METHODS

Hospital admissions of patients receiving immune checkpoint inhibitor (ICI) therapy at a single institution from February 5, 2011, to September 5, 2023, were individually reviewed and adjudicated for the presence of irAEs. ICD codes and an LLM with retrieval-augmented generation were applied to detect frequent irAEs (ICI-induced colitis, hepatitis, and pneumonitis) and the most fatal irAE (ICI-myocarditis) from electronic health records. The performance between ICD codes and LLM was compared via sensitivity and specificity with an α = .05, relative to the gold standard of manual adjudication. External validation was performed using a data set of hospital admissions from June 1, 2018, to May 31, 2019, from a second institution.

RESULTS

Of the 7,555 admissions for patients on ICI therapy in the initial cohort, 2.0% were adjudicated to be due to ICI-colitis, 1.1% ICI-hepatitis, 0.7% ICI-pneumonitis, and 0.8% ICI-myocarditis. The LLM demonstrated higher sensitivity than ICD codes (94.7% 68.7%), achieving significance for ICI-hepatitis ( < .001), myocarditis ( < .001), and pneumonitis ( = .003) while yielding similar specificities (93.7% 92.4%). The LLM spent an average of 9.53 seconds/chart in comparison with an estimated 15 minutes for adjudication. In the validation cohort (N = 1,270), the mean LLM sensitivity and specificity were 98.1% and 95.7%, respectively.

CONCLUSION

LLMs are a useful tool for the detection of irAEs, outperforming ICD codes in sensitivity and adjudication in efficiency.

摘要

目的

在大型回顾性研究中,目前准确识别免疫相关不良事件(irAE)的方法有限。鉴于大语言模型(LLM)在自然语言理解任务中具有高性能,它们为这一挑战提供了一个潜在的解决方案。因此,我们研究了使用大语言模型在住院患者中识别免疫相关不良事件,并将其性能与人工判定和国际疾病分类(ICD)编码进行比较。

方法

对2011年2月5日至2023年9月5日在单一机构接受免疫检查点抑制剂(ICI)治疗的患者的住院记录进行逐一审查,并判定是否存在免疫相关不良事件。应用ICD编码和具有检索增强生成功能的大语言模型从电子健康记录中检测常见的免疫相关不良事件(ICI诱导的结肠炎、肝炎和肺炎)以及最致命的免疫相关不良事件(ICI心肌炎)。相对于人工判定的金标准,通过敏感性和特异性比较ICD编码和大语言模型的性能,α = 0.05。使用来自第二个机构的2018年6月1日至2019年5月31日的住院数据集进行外部验证。

结果

在初始队列中接受ICI治疗的7555例患者中,2.0%被判定为ICI结肠炎所致,1.1%为ICI肝炎,0.

相似文献

1
Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes in Patient Records.提高严重免疫相关不良事件检测的精准度:大型语言模型与患者记录中疾病国际分类代码的比较分析
J Clin Oncol. 2024 Dec 10;42(35):4134-4144. doi: 10.1200/JCO.24.00326. Epub 2024 Sep 3.
2
Validation of Immune-Related Adverse Event (irAE) Case Definitions in a Real-World Lung Cancer Population.真实世界肺癌人群中免疫相关不良事件(irAE)病例定义的验证
Pharmacoepidemiol Drug Saf. 2025 Feb;34(2):e70100. doi: 10.1002/pds.70100.
3
Comparative assessment of manual chart review and ICD claims data in evaluating immunotherapy-related adverse events.比较手动病历审查和 ICD 索赔数据在评估免疫治疗相关不良事件中的应用。
Cancer Immunol Immunother. 2021 Oct;70(10):2761-2769. doi: 10.1007/s00262-021-02880-0. Epub 2021 Feb 24.
4
Identification and Characterization of Immune Checkpoint Inhibitor-Induced Toxicities From Electronic Health Records Using Natural Language Processing.利用自然语言处理从电子健康记录中识别和描述免疫检查点抑制剂诱导的毒性。
JCO Clin Cancer Inform. 2024 Apr;8:e2300151. doi: 10.1200/CCI.23.00151.
5
irAE-GPT: Leveraging large language models to identify immune-related adverse events in electronic health records and clinical trial datasets.免疫相关不良事件生成式预训练变换器(irAE-GPT):利用大语言模型在电子健康记录和临床试验数据集中识别免疫相关不良事件。
medRxiv. 2025 Mar 6:2025.03.05.25323445. doi: 10.1101/2025.03.05.25323445.
6
Patterns and outcomes of immune-related adverse events in solid tumor patients treated with immune checkpoint inhibitors in Thailand: a multicenter analysis.泰国接受免疫检查点抑制剂治疗的实体瘤患者的免疫相关不良事件的模式和结局:一项多中心分析。
BMC Cancer. 2021 Nov 25;21(1):1275. doi: 10.1186/s12885-021-09003-z.
7
Frequency and Consequences of Immune Checkpoint Inhibitor-Associated Inflammatory Changes in Different Organs: An Autopsy Study Over 13 -Years.不同器官中免疫检查点抑制剂相关炎症变化的频率及后果:一项长达13年的尸检研究
Mod Pathol. 2025 Apr;38(4):100683. doi: 10.1016/j.modpat.2024.100683. Epub 2024 Dec 14.
8
Predictors of Rheumatic Immune-Related Adverse Events and De Novo Inflammatory Arthritis After Immune Checkpoint Inhibitor Treatment for Cancer.癌症免疫检查点抑制剂治疗后风湿免疫相关不良事件和新发炎症性关节炎的预测因素。
Arthritis Rheumatol. 2022 Mar;74(3):527-540. doi: 10.1002/art.41949. Epub 2022 Jan 25.
9
Real-World Clinical and Economic Outcomes in Selected Immune-Related Adverse Events Among Patients with Cancer Receiving Immune Checkpoint Inhibitors.癌症患者接受免疫检查点抑制剂治疗的特定免疫相关不良事件的真实世界临床和经济结局。
Oncologist. 2021 Nov;26(11):e2002-e2012. doi: 10.1002/onco.13918. Epub 2021 Aug 24.
10
Late-Onset Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy.免疫检查点抑制剂治疗后的迟发性免疫相关不良事件
JAMA Netw Open. 2025 Mar 3;8(3):e252668. doi: 10.1001/jamanetworkopen.2025.2668.

引用本文的文献

1
Large Language Models for Adverse Drug Events: A Clinical Perspective.用于药物不良事件的大语言模型:临床视角
J Clin Med. 2025 Aug 4;14(15):5490. doi: 10.3390/jcm14155490.
2
Large language model evaluation in autoimmune disease clinical questions comparing ChatGPT 4o, Claude 3.5 Sonnet and Gemini 1.5 pro.在自身免疫性疾病临床问题中对ChatGPT 4o、Claude 3.5 Sonnet和Gemini 1.5 pro进行大语言模型评估。
Sci Rep. 2025 May 21;15(1):17635. doi: 10.1038/s41598-025-02601-y.
3
The baseline circulating immunophenotype characteristics associate with PD(L)-1 targeted treatment response, irae onset, and prognosis.

本文引用的文献

1
Tofacitinib is Effective in Treating Refractory Immune Checkpoint Inhibitor Hepatitis.托法替布治疗难治性免疫检查点抑制剂性肝炎有效。
Clin Gastroenterol Hepatol. 2024 Jul;22(7):1539-1541.e2. doi: 10.1016/j.cgh.2023.12.011. Epub 2023 Dec 22.
2
Generalizability of machine learning methods in detecting adverse drug events from clinical narratives in electronic medical records.机器学习方法在从电子病历中的临床叙述中检测药物不良事件方面的可推广性。
Front Pharmacol. 2023 Jul 12;14:1218679. doi: 10.3389/fphar.2023.1218679. eCollection 2023.
3
Large language models in medicine.
基线循环免疫表型特征与PD(L)-1靶向治疗反应、免疫相关不良反应的发生及预后相关。
Sci Rep. 2025 May 20;15(1):17450. doi: 10.1038/s41598-025-02597-5.
4
Comparing Artificial Intelligence-Generated and Clinician-Created Personalized Self-Management Guidance for Patients With Knee Osteoarthritis: Blinded Observational Study.比较人工智能生成与临床医生创建的针对膝骨关节炎患者的个性化自我管理指导:盲法观察研究。
J Med Internet Res. 2025 May 7;27:e67830. doi: 10.2196/67830.
5
The potential of large language models to advance precision oncology.大语言模型推动精准肿瘤学发展的潜力。
EBioMedicine. 2025 May;115:105695. doi: 10.1016/j.ebiom.2025.105695. Epub 2025 Apr 29.
6
Validation of Immune-Related Adverse Event (irAE) Case Definitions in a Real-World Lung Cancer Population.真实世界肺癌人群中免疫相关不良事件(irAE)病例定义的验证
Pharmacoepidemiol Drug Saf. 2025 Feb;34(2):e70100. doi: 10.1002/pds.70100.
7
Balancing Tumor Immunotherapy and Immune-Related Adverse Events: Unveiling the Key Regulators.平衡肿瘤免疫治疗与免疫相关不良事件:揭示关键调节因子
Int J Mol Sci. 2024 Oct 10;25(20):10919. doi: 10.3390/ijms252010919.
医学中的大型语言模型。
Nat Med. 2023 Aug;29(8):1930-1940. doi: 10.1038/s41591-023-02448-8. Epub 2023 Jul 17.
4
Trends in the approval of cancer therapies by the FDA in the twenty-first century.二十一世纪 FDA 批准癌症疗法的趋势。
Nat Rev Drug Discov. 2023 Aug;22(8):625-640. doi: 10.1038/s41573-023-00723-4. Epub 2023 Jun 21.
5
Immune Checkpoint Inhibitors - The Need for Innovation.免疫检查点抑制剂——创新的必要性。
N Engl J Med. 2023 Apr 20;388(16):1529-1532. doi: 10.1056/NEJMsb2300232.
6
Dysautonomia associated with immune checkpoint inhibitors.免疫检查点抑制剂相关的自主神经功能紊乱。
J Neurol. 2023 Jul;270(7):3413-3423. doi: 10.1007/s00415-023-11667-5. Epub 2023 Mar 20.
7
Rare immune-related adverse events in patients with melanoma: incidence, spectrum, and clinical presentations.黑色素瘤患者罕见的免疫相关不良事件:发生率、谱和临床表现。
Oncoimmunology. 2023 Mar 8;12(1):2188719. doi: 10.1080/2162402X.2023.2188719. eCollection 2023.
8
A text-mining approach to study the real-world effectiveness and potentially fatal immune-related adverse events of PD-1 and PD-L1 inhibitors in older patients with stage III/IV non-small cell lung cancer.一种文本挖掘方法,用于研究 PD-1 和 PD-L1 抑制剂在 III/IV 期非小细胞肺癌老年患者中的真实世界疗效和潜在致命免疫相关不良事件。
BMC Cancer. 2023 Mar 14;23(1):247. doi: 10.1186/s12885-023-10701-z.
9
Dearth of ICD Codes for Complications of Immune Checkpoint Inhibitors Impedes Clinical Care and Research.免疫检查点抑制剂并发症的ICD编码缺失阻碍了临床护理和研究。
J Endocr Soc. 2023 Feb 1;7(4):bvad019. doi: 10.1210/jendso/bvad019. eCollection 2023 Feb 9.
10
Racial disparities in breast cancer treatment patterns and treatment related adverse events.乳腺癌治疗模式和治疗相关不良事件中的种族差异。
Sci Rep. 2023 Jan 22;13(1):1233. doi: 10.1038/s41598-023-27578-4.